Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Der CEO von Philips North America sagte, dass der Einsatz von KI durch Gesundheitsfachleute zunimmt, aber das Potenzial des neuen Technologien noch nicht ausgeschöpft sei. KI könne die Qualität der Arbeit und des Lebens von Ärzten verbessern, indem sie die Fokusbereiche einschränke und den Burnout reduziere.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

NEW YORK, 9. Juni (Reuters) - Künstliche Intelligenz hilft dabei, die Genauigkeit in der Patientenversorgung zu verbessern und in einigen Fällen Zeit und Geld zu sparen, sagte der CEO des nordamerikanischen Philips-Divisions, Jeff DiLullo. Die Technologie wird den Beruf von Ärzten im Gesundheitswesen langfristig verändern, sagte DiLullo, insbesondere die Arbeitsproduktivität werde steigen. "Der Median der zusätzlichen Patienten, die sie pro Woche treffen können, ist fünf", sagte DiLullo. "Das hat eine wirtschaftliche Bedeutung für ein Gesundheitssystem."

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Royal Philips

Clinician and AIClinician and AI·GlobeNewswire Inc.

A healthcare professional and patient on a benchA healthcare professional and patient on a bench·GlobeNewswire Inc.

FHI 2026 global cover imageFHI 2026 global cover image·GlobeNewswire Inc.

Healthcare professionals in discussionHealthcare professionals in discussion·GlobeNewswire Inc.

June 9, 2026

AI saves clinicians the equivalent of 16 working days a year, with half saying it has increased their capacity to see patients 39% say AI has identified or helped prevent potential medical errors at least three times in the past three months 70% of healthcare professionals say AI training is inadequate, inconsistent or unavailable

Amsterdam, the Netherlands – AI is already saving clinicians the equivalent of over 16 working days a year and helping them see more patients, but healthcare systems risk falling behind because of inadequate training and fragmented infrastructure. That’s according to findings from Philips’ Future Health Index 2026, the 11th edition of the global report, based on perspectives from over 2,000 healthcare professionals and 20,000 patients across 10 countries.

AI is transforming care delivery The Future Health Index 2026 findings demonstrate how AI is already actively reshaping care delivery into a more hybrid, extended care team model.

Nearly two-thirds (65%) of clinicians have increased their use of AI tools provided at work, with measurable benefits. Clinicians say AI saves them time every week. Close to half (46%) reported time savings of at least 132 hours annually on average, or the equivalent of more than three full working weeks. 50% report they have more capacity to see patients, on average eight more patients per week.

This freed time is reinvested into higher-value clinical work and patient relationships – fundamentally changing how care is being delivered.

Shez Partovi, Chief Innovation Officer at Philips: “What is really encouraging is that AI is already making a tangible difference in everyday clinical practice, for clinicians and patients alike. We are seeing people save meaningful time, care for more patients, and feel better at work. At its heart, AI is there to support healthcare professionals, giving them more room to focus on what matters most: clinical decision-making and patient care. At the same time, we see many health systems are still early in their AI journey, and there's real work ahead on infrastructure and training.”

Downloadthe Philips Future Health Index 2026 report to learn more. Clinicians report less stress, more confidence, safer care By automating routine tasks and streamlining workflows, AI also reduces emotional and cognitive load for clinicians. Half report less work-related stress (49%) and two-thirds (65%) report greater confidence in decision-making. Notably, 39% have already seen AI identify or prevent potential medical errors at least three times in the past three months.

Story Continues

“Clinicians are beginning to experience AI not as an abstract technology, but as something that meaningfully changes clinical safety,” said Ami Bhatt, MD, Chief Innovation Officer, American College of Cardiology.

Many healthcare systems are playing catch-up with AI While many healthcare professionals report improved workflow efficiency, AI adoption has exposed gaps in organizational readiness. Some healthcare systems are already realizing significant returns, while others struggle to move beyond pilot programs. Integrating AI into care remains complex, particularly where fragmented healthcare IT environments and limited interoperability make it difficult to deploy AI consistently across teams and care settings. These barriers can slow implementation and limit the ability to scale AI effectively in practice.

A majority (59%) of clinicians say their organization’s leadership are taking the right steps to implement AI. Yet uneven progress and lack of training expose the untapped opportunity – 7 in 10 (70%) clinicians report inadequate, inconsistent, or unavailable training. The top training needs include checking the accuracy of AI recommendations developing technical navigation skills and understanding legal liability.

The report findings point to a healthcare sector in transition: AI is already reshaping care, yet adoption varies widely across organizations and care settings. Its impact is transforming care but the next phase depends on effective implementation, integration and support across healthcare systems. Expanding access to the right tools and training, alongside strong clinical leadership, clear governance and organizational support, will be critical to helping clinicians adopt AI confidently and consistently in practice. Ultimately enabling more time for patient care and higher-value clinical work.

Patients are increasingly using AI to support clinician consultations Clinicians are now working at their best, with 82% seeing or expecting their roles to move to higher-value activities, and 71% say AI will help them to work at the top of their capabilities. Patients are also considered active partners in their care. Three-quarters (74%) of clinicians report patients arriving at consultations AI-informed and 63% of them regard informed patients as integral future partners in their extended, hybrid team. Over half of patients (56%) predict that AI will help them take a more active role in their care in the future.

“Time savings translate into more than operational efficiencies,” said Carla Goulart Peron, Chief Medical Officer at Philips. “Half of the clinicians we surveyed report experiencing less stress and a better work-life balance. Patients experience these benefits directly through higher-quality interactions, the attention they receive during appointments and the time clinicians have to listen. As a clinician, I know that trust is built through human connection, and creating more time for those moments benefits everyone.”

About the Future Health Index 2026 The Future Health Index is the largest global survey of its kind, analyzing the perspectives of healthcare professionals and patients across multiple countries. Based on proprietary quantitative research involving over 2,000 healthcare professionals and more than 20,000 patients across 10 countries, the 2026 edition examines how AI is actively being used across healthcare systems and the value it creates in time regained, expanded capacity, and improvements in care delivery. For more information, or to download the full report, visit www.philips.com/futurehealthindex-2026.

Contact: Kees Verheij Philips Global External Relations Tel: +31 634557732 E-mail: Kees.Verheij@philips.com

About Royal PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2025 sales of approximately EUR 18 billion and employs approximately 64,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

Clinician and AI A healthcare professional and patient on a bench FHI 2026 global cover image Healthcare professionals in discussion FHI 2026 global report infographic

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Philips Future Health Index 2026 Animated InfographicPhilips Future Health Index 2026 U.S. Data One-Pager

New findings show AI helping clinicians expand capacity, reduce burnout and deliver better care for more people amid rising demand, workforce shortages and increasing costs

CAMBRIDGE, Mass., June 09, 2026--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today released its 2026 Future Health Index U.S. report, "AI in practice: Shaping the future of healthcare now," revealing how AI is delivering measurable benefits across healthcare systems under growing strain. The report shows AI increasingly embedded into clinical workflows, helping clinicians regain time, improve decision-making, expand patient capacity and reduce administrative burden.

Among the key findings from the U.S. report:

More than one-third of healthcare professionals (36%) say AI has increased their capacity to see more patients, with clinicians reporting a median increase of five additional patients per week. Clinicians say AI saves them time every week. Nearly half (49%) reported time savings of at least 132 hours per year on average, or the equivalent of more than three full working weeks – time spent on higher-value clinical tasks such as thinking through cases in more detail. More than one-quarter of healthcare professionals (27%) say AI has helped them identify or prevent a potential medical error at least three times in the past three months, underscoring AI’s growing role in supporting safer care and clinical decision-making. Clinicians also report meaningful improvements in well-being, including better work-life balance (35%), reduced work-related stress (36%) and less overtime or taking work home (32%).

The report shows that AI adoption is becoming nearly universal among healthcare providers, with three-quarters (74%) of clinicians saying their use of AI-enabled tools provided by their organization has increased over the past year and a similar number (73%) say the use of AI-enabled tools is resulting in time-savings. Clinicians report using that regained time to focus more on patient care, clinical decision-making and higher-value tasks while also using that time to keep up to date with research and clinical developments and the ability to apply greater precision to their work.

Emerging from this year’s report is the advent of a new "hybrid care team," where AI supports clinicians and patients while human judgment remains central to care. A majority of clinicians are comfortable with AI supporting decisions as a ‘partner’ when it comes to diagnostic decision support tools, medical image analysis tools, medical imaging processing systems and surgical guidance systems, amongst others. Importantly, more than 90% say it is essential to keep a human in the loop as AI advances.

Story Continues

At the same time, the findings point to ongoing readiness challenges. Nearly eight in 10 healthcare professionals say training for AI-enabled tools is limited or inconsistent at their organization, underscoring the need for stronger infrastructure, workforce readiness and governance as AI adoption accelerates.

"The growth in adoption of AI over the last year has been nothing short of remarkable – and healthcare leaders are increasingly seeing an AI dividend. Their investments are giving time back to clinicians and improving the patient experience," said Jeff DiLullo, Chief Region Leader, Philips North America. "We’re still in the early days of this transformation. To realize these benefits across the broader healthcare ecosystem and have impact at scale, AI must be embedded seamlessly into clinical workflows and supported by consistent education and training."

About the Future Health Index 2026

The Future Health Index is the largest global survey of its kind, analyzing the perspectives of healthcare professionals and patients across multiple countries. Based on proprietary quantitative research involving over 2,000 healthcare professionals and more than 20,000 patients across 10 countries, the 2026 edition examines how AI is actively being used across healthcare systems and the value it creates in time regained, expanded capacity and improvements in care delivery. For more information, or to download the full U.S. report, visit www.usa.philips.com/futurehealthindex-2026.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2025 sales of EUR 18 billion and employs approximately 64,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260609219865/en/

Contacts

Avi Dines Philips North America Tel: +1-781-690-3814 Email: avi.dines@philips.com

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Steve Pocock hat seine Entscheidung, am 30. Juni 2026 in den Ruhestand zu treten, bekannt gegeben. John Smith wird zum Vizepräsidenten für Architektur-Coatings EMEA ernannt und tritt am 1. Juli 2026 in sein Amt ein.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Royal Philips und WellSpan Health haben eine siebenjährige Partnerschaft vereinbart, um gemeinsam fortgeschrittene Bildgebungs-, KI- und digitale Gesundheitstools zu entwickeln und zu testen. Philips hat auch die FDA-Zulassung für Elevate Plus erhalten, ein durch KI angetriebenes Ultraschallplattform, das zur Unterstützung von Automatisierung und klinischen Workflows gedacht ist.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Royal Philips hat eine siebenjährige Zusammenarbeit mit WellSpan Health eingeleitet. Ziel ist es, die Diagnose- und Bildgebungstechnologie in der Gemeinschaftsgesundheitspflege voranzutreiben. Die Partnerschaft umfasst ein Forschungsabkommen und einen gemeinsamen Innovationsstrategie, der erste seiner Art zwischen Philips und einem US-amerikanischen Gemeinschafts-Gesundheitssystem.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Die Koninklijke Philips N.V. (NYSE: PHG, AEX: PHIA) hat heute mitgeteilt, dass das Austauschverhältnis für die Dividende des Jahres 2025 1 neue Aktie für jede 26,9341 bestehenden Aktien beträgt. Dieses Verhältnis wurde auf der Grundlage des volume-gewichteten Durchschnittspreises aller gehandelten Aktien Koninklijke Philips N.V. an Euronext Amsterdam am 27., 28. und 29. Mai 2026, von EUR 22,8640 berechnet. Als Ergebnis wird Philips insgesamt 19.964.655 neue Aktien ausgeben. Die Aktionäre haben die Möglichkeit, zwischen einer Dividende in Aktien oder in Bargeld zu wählen. Das Gesamtergebnis der Bargeldelektionsentscheidung betrug 43,8 %. Die Ausgabe neuer Aktien sowie die Abrechnung von Bruchteilen in Bargeld und die Zahlung der Bargelddividende werden ab dem 3. Juni 2026 auf der Grundlage der Dividendenberechtigung am Dividendenstichtag erfolgen.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Die preisgekrönte Creative-Leaderin Mariana O'Kelly wird die kreative Vision von Doner und Colle McVoy prägen. Sie bringt fast 30 Jahre globale kreative Führungserfahrung mit, darunter für ikonische Marken wie KFC, Philips, Kellogg's und Campbell's.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Royal Philips hat mit der Ambient Experience für MRI eine neue Technologie entwickelt, die Disney-Geschichten und -Charaktere integriert. Diese Technologie soll Kinder während ihrer MRI-Untersuchungen beruhigen und ihnen helfen, stillzuhalten. Die Studie zeigt, dass die Anwesenheit von Disney-Themen bei Kindern zwischen 6 und 10 Jahren den Stresspegel um 43% reduzierte und die Pausezeit während der Untersuchung um 63% sank.